Knockdown of AKT2 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to the anticancer drug VM-26 in U87 glioma cells

[1]  Feng-peng Wang,et al.  H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2. , 2011, Biochemical pharmacology.

[2]  Hua He,et al.  Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine , 2011, Brain Research Bulletin.

[3]  Guoyou Zhang,et al.  Knockdown of Akt Sensitizes Osteosarcoma Cells to Apoptosis Induced by Cisplatin Treatment , 2011, International journal of molecular sciences.

[4]  Erwin G. Van Meir,et al.  Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma , 2010, CA: a cancer journal for clinicians.

[5]  R. Niu,et al.  Reduction of Akt2 inhibits migration and invasion of glioma cells , 2009, International journal of cancer.

[6]  J. Delattre,et al.  Role of ABC transporters in the chemoresistance of human gliomas. , 2006, Current cancer drug targets.

[7]  A. Toker,et al.  Akt signaling and cancer: surviving but not moving on. , 2006, Cancer research.

[8]  C. Marras,et al.  Expression of Drug Resistance Proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in Human Glioma , 2005, Journal of Neuro-Oncology.

[9]  Wolfgang Löscher,et al.  Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases , 2005, Progress in Neurobiology.

[10]  K. Aldape,et al.  Expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Expression of Vascular Endothelial Growth Factor in and Angiogenic Phenotype of Human Gastric Cancer , 2005, Clinical Cancer Research.

[11]  R. Grobholz,et al.  Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer , 2003, International journal of cancer.

[12]  S. Spiegl-Kreinecker,et al.  Expression and Functional Activity of the ABC-transporter Proteins P-glycoprotein and Multidrug-resistance Protein 1 in Human Brain Tumor Cells and Astrocytes , 2002, Journal of Neuro-Oncology.

[13]  H. Nakayama,et al.  High expression levels of nuclear factor κB, IκB kinase α and Akt kinase in squamous cell carcinoma of the oral cavity , 2001 .

[14]  J. Yamashita,et al.  Expression of Multidrug Resistance-associated Protein (MRP) in Human Gliomas , 2000, Journal of Neuro-Oncology.

[15]  T. Batchelor,et al.  New treatment strategies for malignant gliomas. , 1999, The oncologist.

[16]  Y. Rustum,et al.  MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. , 1996, The American journal of pathology.

[17]  J. Cheng,et al.  Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Cheng,et al.  Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas , 1995, International journal of cancer.

[19]  J. Cheng,et al.  AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Walker,et al.  4′‐Demethyl‐epipodophyllotoxin‐β‐D‐thenylidene‐glucoside (PTG) in the treatment of malignant intracranial neoplasms , 1974 .

[21]  J. Cheng,et al.  The Effects of Antisense AKT2 RNA on the Inhibition of Malignant Glioma Cell Growth in vitro and in vivo , 2005, Journal of Neuro-Oncology.

[22]  M. Saji,et al.  Carcinoma Overexpression and Overactivation of Akt in Thyroid Updated , 2001 .

[23]  Jiayuh Lin,et al.  Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis. , 2000, Anticancer research.